[Elsevier] Safety, tolerability, and efficacy of flexible-dose tavapadon for Parkinson's disease (TEMPO-2): a phase 3, randomised, placebo-controlled, double-blind trial |
|
This post will be closed automatically in 2026-07-28 16:41
Best Answer
1 hour(s) ago
|
| |
post
reply
points
30
10
MXene-enabled interfaces and architectures for high-performance zinc anodes in aqueous zinc-ion batteries
10
Control of Hybrid Dynamical Systems
10
Classical Frequency Response Design Methods
10
Passivity-Based Nonlinear Control
10
Optimizing molybdenum-cobalt (Mo-Co) ratio in phosphorus enriched CoMoP nanorods for enhanced hydrogen evolution performance
